Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: Relevance for type 1 diabetes

Pediatric Diabetes

Volumn 14, Issue 2, 2013, Pages 81-89

  Takiishi, Tatiana ^a   Van Belle, Tom ^a   Gysemans, Conny ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antigen; Immune modulation; Therapy; Type 1 diabetes; Vitamin D

Indexed keywords

ANTIGEN; B7 ANTIGEN; CALCITRIOL; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; COLECALCIFEROL; ERGOCALCIFEROL; GAMMA INTERFERON; GLUCOSE 6 PHOSPHATASE; GLUTAMATE DECARBOXYLASE; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 LIGAND 1; PROINSULIN; T6 ANTIGEN; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STRUCTURE; CELL TYPE; CLINICAL PRACTICE; CYTOKINE RELEASE; DENDRITIC CELL; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; RISK REDUCTION; T LYMPHOCYTE ACTIVATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOMODULATION; IMMUNOTHERAPY; INSULIN-SECRETING CELLS; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84874489590     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00923.x     Document Type: Review

References (72)

1. Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog Biophys Mol Biol 2006: 92: 33-38.
2. Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011: 25: 531-541.
3. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009: 94: 26-34.
4. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010: 10: 482-496.
5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998: 392: 245-252.
6. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000: 374: 334-338.
7. Ferreira GB, van Etten E, Verstuyf A et al. 1, 25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 2011: 27: 933-941.
8. Adorini L, Penna G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 2009: 251-273.
9. Penna G, Roncari A, Amuchastegui S et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T-cells by 1, 25-dihydroxyvitamin D3. Blood 2005: 106: 3490-3497.
10. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 2009: 39: 3147-3159.
11. Azzaoui I, Yahia SA, Chang Y et al. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T-cells in healthy subjects. Blood 2011: 118: 3549-3558.
12. Ferreira GB, van Etten E, Lage K et al. Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009: 9: 3752-3764.
13. van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1, 25 dihydroxyvitamin D(3). Diabetes 2002: 51: 2119-2125.
14. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T-cells. J Cell Biochem 2003: 89: 922-932.
15. Cantorna MT. Why do T-cells express the vitamin D receptor? Ann N Y Acad Sci 2011: 1217: 77-82.
16. Baeke F, Korf H, Overbergh L et al. The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011: 186: 132-142.
17. Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab 2011: 25: 617-632.
18. Giulietti A, Gysemans C, Stoffels K et al. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 2004: 47: 451-462.
19. Jeffery LE, Burke F, Mura M et al. 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T-cells expressing CTLA-4 and FoxP3. J Immunol 2009: 183: 5458-5467.
20. Palmer MT, Lee YK, Maynard CL et al. Lineage-specific effects of 1, 25-dihydroxyvitamin D(3) on the development of effector CD4 T-cells. J Biol Chem 2011: 286: 997-1004.
21. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007: 179: 1634-1647.
22. Dai YD, Carayanniotis G, Sercarz E. Antigen processing by autoreactive B-cells promotes determinant spreading. Cell Mol Immunol 2005: 2: 169-175.
23. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001: 358: 1500-1503.
24. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D3. Diabetologia 1994: 37: 552-558.
25. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha, 25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002: 51: 1367-1374.
26. Zella JB, McCary LC, DeLuca HF. Oral administration of 1, 25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 2003: 417: 77-80.
27. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 2011: 347: 106-120.
28. Mathieu C, van Etten E, Gysemans C, Decallonne B, Bouillon R. Seasonality of birth in patients with type 1 diabetes. Lancet 2002: 359: 1248.
29. Driver JP, Foreman O, Mathieu C, van Etten E, Serreze DV. Comparative therapeutic effects of orally administered 1, 25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet. Clin Exp Immunol 2008: 151: 76-85.
30. Gysemans CA, Cardozo AK, Callewaert H et al. 1, 25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005: 146: 1956-1964.
31. Decallonne B, van Etten E, Overbergh L, Valckx D, Bouillon R, Mathieu C. 1Alpha, 25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells. J Autoimmun 2005: 24: 281-289.
32. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010: 39: 419-446, Table of contents.
33. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008: 93: 512-517.
34. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 1999: 42: 51-54.
35. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000: 43: 1093-1098.
36. Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003: 78: 1128-1134.
37. Fronczak CM, Baron AE, Chase HP et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 2003: 26: 3237-3242.
38. Tenconi MT, Devoti G, Comelli M et al. Major childhood infectious diseases and other determinants associated with type 1 diabetes: a case-control study. Acta Diabetol 2007: 44: 14-19.
39. Wicklow BA, Taback SP.Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk. Ann N Y Acad Sci 2006: 1079: 310-312.
40. Aljabri KS, Bokhari SA, Khan MJ.Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency.Ann Saudi Med 2010: 30: 454-458.
41. ClinicalTrials.gov. A Service of the U.S. National Institutes of Health (available from http://clinicaltrials.gov).
42. Pitocco D, Crino A, Di Stasio E et al.The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset type 1 diabetes (IMDIAB XI). Diabet Med 2006: 23: 920-923.
43. Li X, Liao L, Yan X et al. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2009: 25: 411-416.
44. Bizzarri C, Pitocco D, Napoli N et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010: 33: 1962-3.
45. Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG. No effect of the 1alpha, 25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 2010: 33: 1443-1448.
46. Wagner CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW.High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med 2006: 1: 59-70.
47. Marjamaki L, Niinisto S, Kenward MG et al.Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010: 53: 1599-1607.
48. Bock G, Prietl B, Mader JK et al. The effect of vitamin D supplementation on peripheral regulatory T-cells and beta cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 2011: 27: 942-945.
49. Arif S, Tree TI, Astill TP et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004: 113: 451-463.
50. Vehik K, Cuthbertson D, Ruhlig H et al. Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes Care 2011: 34: 1585-1590.
51. Harrison LC, Honeyman MC, Steele CE et al. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 2004: 27: 2348-2355.
52. Fourlanos S, Perry C, Gellert SA et al. Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes. Diabetes 2011: 60: 1237-1245.
53. Ludvigsson J, Krisky D, Casas R et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med 2012: 366: 433-442.
54. Niens M, Grier AE, Marron M, Kay TW, Greiner DL, Serreze DV. Title>Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach. Diabetes 2011: 60: 1229-1236.
55. Nicholas D, Odumosu O, Langridge WH. Autoantigen based vaccines for type 1 diabetes. Discov Med 2011: 11: 293-301.
56. Tsai S, Shameli A, Yamanouchi J et al. Reversal of autoimmunity by boosting memory-like autoregulatory T-cells. Immunity 2010: 32: 568-580.
57. van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO.1alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T-cells via the selective induction of apoptosis. J Autoimmun 2004: 23: 233-239.
58. Ali MA, Thrower S, Harris S, Wong S, Dayan C. Effects of topical betamethasone and calcipotriol therapy in improving the tolerogenic potential of a 'vaccine' for type 1 diabetes. Society for Endocrinology BES 2011, Birmingham, UK, 2011.
59. Mishra N, Gupta PN, Khatri K, Goyal AK, Vyas SP. Edible vaccines: a new approach to oral immunization. Indian J Biotechnol 2008: 7: 283-294.
60. Takiishi T, Korf H, Van Belle TL et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest 2012: 122: 1717-1725.
61. Ferreira GB, Kleijwegt FS, Waelkens E et al. Differential protein pathways in 1, 25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res 2012: 11: 941-971.
62. Naranjo-Gomez M, Raich-Regue D, Onate C et al. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med 2011: 9: 89.
63. Gorman S, Kuritzky LA, Judge MA et al. Topically applied 1, 25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol 2007: 179: 6273-6283.
64. Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specific regulatory T-cells with the topical vitamin d analog calcipotriol. J Immunol 2009: 182: 6071-6078.
65. Loser K, Mehling A, Loeser S et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006: 12: 1372-1379.
66. Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo BA. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 1996: 64: 1100-1109.
67. Ivanov AP, Dragunsky EM, Chumakov KM. 1, 25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J Infect Dis 2006: 193: 598-600.
68. Enioutina EY, Bareyan D, Daynes RA. TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 2008: 26: 601-613.
69. Overbergh L, Decallonne B, Waer M et al. 1alpha, 25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000: 49: 1301-1307.
70. Sigmundsdottir H, Pan J, Debes GF et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007: 8: 285-293.
71. Kleijwegt FS, Laban S, Duinkerken G et al.Critical role for TNF in the induction of human antigen-specific regulatory T-cells by tolerogenic dendritic cells. J Immunol 2010: 185: 1412-1418.
72. van der Aar AM, Sibiryak DS, Bakdash G et al. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T-cells. J Allergy Clin Immunol 2011: 127: 1532-1540.